Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Keratosis, Actinic × LEO 43204 × Clear all

Phase

Phase 1/2 2 Phase 3 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 1

Interventions

3-ingenyl angelate 7 Radiotherapy 3 Prilocaine 3 Lidocaine 3 Imiquimod 2 Gels 2 BF-200 ALA 2 Aminolevulinic Acid 2 calcipotriene 1 beta-solamarine 1 Vitamin D 1 Solutions 1 Powders 1 Niacinamide 1 LEO 43204 1 Imipramine 1 Fluorouracil 1 Diclofenac 1 Celecoxib 1 Aluminum Chloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02650505 2025-02-24

A Clinical Study to Evaluate the Sensitizing Potential of LEO 43204 Gel

LEO Pharma

Phase 1 Completed

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡